JUBILANT Stock Analysis

<div class='circular--portrait' style='background:#006400;color: #FFE4E1;font-size:4em;padding-top: 25px;;'>JL</div>
JUBILANT -- India Stock  

INR 688.95  7.05  1.01%

The latest price spikes of JUBILANT LIFE SCIE may raise some interest from institutional investors. The stock closed today at a share price of 681.0 on very low momentum in trading volume. The company directors and management may have good odds in positioning the firm resources to exploit market volatility in August. The stock standard deviation of daily returns for 30 days investing horizon is currently 3.73. The above-average risk is mostly attributed to market volatility and speculations regarding some of the upcoming earning calls from JUBILANT LIFE SCIE partners. Please see Risk vs Return Analysis.

Search Stock Analysis

 
Refresh
The JUBILANT LIFE stock analysis makes it easy to digest most publicly released information about JUBILANT LIFE and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. JUBILANT stock analysis module also helps to analyze the JUBILANT LIFE price relationship with some important fundamental indicators such as market cap and management efficiency.

JUBILANT Stock Analysis Notes

About 55.0% of the company shares are held by company insiders. The company has price-to-book ratio of 1.85. Some equities with similar Price to Book (P/B) outperform the market in the long run. JUBILANT LIFE SCIE recorded earning per share (EPS) of 56.39. The entity last dividend was issued on the 9th of March 2020. The firm had a split on the 25th of November 2010. Jubilant Life Sciences Limited operates as an integrated pharmaceutical and life sciences company worldwide. The company was incorporated in 1978 and is based in Noida, India. JUBILANT LIFE operates under Drug ManufacturersSpecialty Generic classification in India and is traded on National Stock Exchange of India. It employs 8000 people. To learn more about JUBILANT ORGANOSY call the company at 91 12 0436 1000 or check out http://www.jubl.com.

JUBILANT LIFE SCIE Investment Alerts

JUBILANT LIFE SCIE appears to be very risky and stock price may revert if volatility continues
About 55.0% of the company shares are held by company insiders

Market Capitalization

The company currently falls under 'Mega-Cap' category with current market capitalization of 103.21 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate JUBILANT LIFE's market, we take the total number of its shares issued and multiply it by JUBILANT LIFE's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Profitablity

The company has Profit Margin (PM) of 9.81 %, which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 16.22 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.16.

Management Efficiency

The entity has return on total asset (ROA) of 7.74 % which means that it generated profit of $7.74 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 17.25 %, meaning that it generated $17.25 on every $100 dollars invested by stockholders. JUBILANT LIFE management efficiency ratios could be used to measure of how well jubilant life scie is managing its routine affairs as well as how well it utilizes its assets and manages liabilities.

Technical Drivers

As of the 16th of July 2020, JUBILANT LIFE owns the semi deviation of 6.56, downside deviation of 10.32, and market risk adjusted performance of (22.55). JUBILANT LIFE SCIE technical analysis makes it possible for you to employ past data patterns with the intention to determine a pattern that calculates the direction of the firm's future prices. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume patterns, or the prices will eventually revert. We were able to break down and interpolate nineteen technical drivers for JUBILANT LIFE, which can be compared to its peers in the sector. Please check out JUBILANT LIFE SCIE jensen alpha, and the relationship between the coefficient of variation and potential upside to decide if JUBILANT LIFE SCIE is priced some-what accurately, providing market reflects its prevailing price of 688.95 per share.

JUBILANT LIFE SCIE Price Movement Analysis

The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Mid-point Price over period is an average of JUBILANT LIFE SCIE highest and lowest prices attained during the given period. View also all equity analysis or get more info about midpoint price over period overlap studies indicator.

JUBILANT LIFE Technical and Predictive Indicators

JUBILANT LIFE Forecast Models

About JUBILANT LIFE Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how JUBILANT LIFE stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling JUBILANT shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as JUBILANT LIFE. By using and applying JUBILANT Stock analysis, traders can create a robust methodology for identifying JUBILANT entry and exit points for their positions.
Jubilant Life Sciences Limited operates as an integrated pharmaceutical and life sciences company worldwide. The company was incorporated in 1978 and is based in Noida, India. JUBILANT LIFE operates under Drug ManufacturersSpecialty Generic classification in India and is traded on National Stock Exchange of India. It employs 8000 people.

Did you try this?

Run Sync Your Broker Now

   

Sync Your Broker

Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
All  Next Launch Module
Please see Risk vs Return Analysis. Please also try Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page